Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion. [electronic resource]

By: Contributor(s): Producer: 20200911Description: viii31-viii35 p. digitalISSN:
  • 1569-8041
Subject(s): Online resources: In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 30 Suppl 8
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.